← Back to all signals
RESEARCH PAPER ANALYSIS

Early Palliative Care Is Feasible and Acceptable in Pediatric Neuro-Oncology.

AI interpretation is pending for this paper.

Open original publication →
PMID42747124
JournalPediatric blood & cancer
Publication Date2026-09-16
Ingested2026-09-17 09:15 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

BACKGROUND: Children with central nervous system (CNS) tumors face high morbidity and mortality, yet often do not receive palliative care (PC). There is evidence of the benefit of PC in pediatric oncology, though the ideal timing remains unknown. We aimed to evaluate the feasibility and acceptability of early PC for children with high-risk CNS tumors. PROCEDURES: Children at Children's of Alabama with CNS tumors (2019-2022) with high mortality risk (e.g., glioblastoma) were referred to PC at the time of diagnosis/relapse, facilitated by PC and research assistants attending neuro-oncology clinical team meetings. PC aimed to see children within 2 weeks of index event (IE), then as clinically indicated. For feasibility, we assessed time from IE to PC consult and total PC visits. For acceptability, we conducted semi-structured interviews with parents and clinicians about perceptions of early PC. RESULTS: Eighteen children (nine female, 14 non-Hispanic White) were eligible. Median IE age was 6 years (interquartile range [IQR] = 2-11 years). All children saw PC; median of 11 days (IQR = 4-20 days) after their IE, with a median of eight (IQR = 4-20) PC visits. Fourteen parents (11 female, nine non-Hispanic White) and nine clinicians (five physicians, four nurse practitioners) were interviewed. Parents and clinicians reported benefits in symptom management, decisional and family support, and preservation of hope. Clinicians benefited from partnering in complex care and learning PC skills. Notably, caregivers appreciated PC involvement, yet clinicians were anxious about introducing PC. CONCLUSIONS: This study demonstrates the feasibility and acceptability of early PC in pediatric neuro-oncology; however, clinician, but not family, discomfort with early PC remains a barrier.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Impact of Transport Media on IL-33 Levels in Samples From Patients With Viral Respiratory Infections. Journal of immunology research 58.2 2 Eosinophilic Fasciitis in Children: A Case Report. Cureus 51.4 3 Sporadic Burkitt Lymphoma Presenting as Refractory Iron-Deficiency Anemia in a Three-Year-Old Boy: A Case Report. Cureus 49.52 4 Measurable residual disease detected by next-generation sequencing in T-cell acute lymphoblastic leukemia. Nature communications 61.2 5 Postoperative antibiotic continuation does not reduce infectious complications after elective pediatric ostomy reversal: A NSQIP Pediatric analysis. Journal of pediatric surgery 68.5 6 A Phase Ib Case Series Using Bortezomib With Chemotherapy in Atypical Teratoid/Rhabdoid Tumors. Cancer medicine 84.54 7 Metabolic reprogramming-related drug resistance in osteosarcoma: from molecular mechanisms to therapeutic translation. Frontiers in molecular biosciences 86.25 8 Pembrolizumab-induced type-1 diabetes mellitus: clinical characteristics, therapeutic strategies, and prognosis from a retrospective analysis of 43 published cases. Frontiers in endocrinology 65.74 9 Feeding and swallowing function and dysphagia risk in children with posterior fossa tumors: a preliminary Italian cohort study. Frontiers in oncology 67.0 10 The global landscape of pediatric monoclonal antibody (mAb) clinical trials: an analysis of ClinicalTrials.gov. Frontiers in pediatrics 73.16 11 Lipidomic analysis of isolated lipid droplets reveals potential metabolic pathway differences between medulloblastoma subgroups. Frontiers in neuroscience 56.0 12 Case Report: Selumetinib as a neoadjuvant treatment for the removal of a PN. Frontiers in pediatrics 50.74 13 PACSIN2 regulates mercaptopurine cytotoxicity and cellular biomechanics through Rac1 modulation in intestinal epithelial cells. Frontiers in pharmacology 58.42 14 Enhancing Communication and Consent Using 3-D Printed Models With a Pediatric Dental Patient Presenting With Odontogenic Keratocysts Associated With Gorlin Syndrome: A Case Report. Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry 47.5 15 Respiratory Syncytial Virus-Associated Disease in Children Receiving Intensive Care. JAMA network open 64.5 16 A comprehensive survey of genetic variants in neuroblastoma. Journal, genetic engineering & biotechnology 59.9 17 The role of CHAMP1 in chromatin-mediated DNA damage repair. DNA repair 60.6 18 Experiences and coping strategies of time toxicity in young and middle-aged patients with lymphoma: a descriptive qualitative study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 64.72 19 Vertigo and dizziness syndromes in children and adolescents: Clinical presentation and diagnostic pathway. Developmental medicine and child neurology 62.0 20 Antidepressant and antipsychotic prescriptions among 21 605 English survivors of childhood cancer: a population-based cohort. Journal of the National Cancer Institute 59.9 21 Prolonged Headache in a 13-Year-Old Girl With Acute Lymphoblastic Leukemia: A Case of Possible Neuroinflammatory Complication Responsive to Intravenous Immunoglobulin. Clinical case reports 47.8 22 Assessment of Potentially Toxic and Essential Metals in Commonly Consumed Tomato Ketchup Brands from Local Markets in Faisalabad, Pakistan, and Associated Health Risks. Biological trace element research 57.5 23 MRI-based radiomics for prognosis of non-midline, pediatric high-grade gliomas. Journal of neuro-oncology 81.0 24 Mapping an Overlooked Spiral of Trauma-Exposure to Sexual Abuse and Psycho-Spiritual Outcomes in Patients With Cancer: A Systematic Review and Meta-Analysis. Cancer nursing 79.0 25 Establishing the First National Fanconi Anemia Registry in Iran: Clinical and Epidemiological Insights From 116 Patients. Pediatric blood & cancer 61.5 26 New and emerging somatostatin therapies for neuroendocrine tumors: "what is in the pipeline". Expert opinion on pharmacotherapy 69.1 27 Infection profile and risk factors for adverse outcomes in children with febrile neutropenia: a single-center study from Northwestern India. Pediatric hematology and oncology 62.0 28 Cryptic PML::RARA With Concurrent RUNX1::RUNX1T1 in an Adolescent With Acute Promyelocytic Leukemia. Pediatric blood & cancer 47.5 29 Body Composition and Physical Activity are Associated With Prediabetes in Childhood, Adolescent, and Young Adult Cancer and Hematopoietic Cell Transplantation Survivors. Pediatric blood & cancer 54.0 30 Transverse Myelitis and Guillain-Barré Syndrome in Pediatric Lymphoid Malignancies: An International Retrospective Study. Pediatric blood & cancer 65.1 31 Cost-Effectiveness of Early Empirical Antibiotic Cessation in Pediatric High-Risk Febrile Neutropenia. Pediatric blood & cancer 62.9 32 Factors associated with early death among children and adolescents with cancer in Brazil: a nationwide registry-based study. Pediatric hematology and oncology 70.3
PATIENT-FRIENDLY SUMMARY

Early Palliative Care Is Feasible and Acceptable in Pediatric Neuro-Oncology.

For education only—not personal medical advice.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic